Article

Three femtosecond laser comparisons: IntraLase FS30 comes out on top

The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.

The IntraLase femtosecond FS30 laser creates a more predictable and more stable flap thickness than the Hansatome XP microkeratome (Bausch & Lomb) and the IntraLase femtosecond FS2 laser, according to research conducted by Baha Toygar and colleagues from Turkey.

A prospective study of the three LASIK procedures was performed in 303 eyes of 167 patients. Each procedure was carried out by the same surgeon. The Hansatome XP microkeratome with 120 µm head was used on 92 eyes (Group A). The IntraLase FS2 15 Hertz laser was used to create a 120 µm flap in 100 eyes (Group B) and the IntraLase FS30 30 Hertz laser was used to create a 120 µm flap in 111 eyes (Group C). Flap thickness was measured by subtraction of intraoperative stromal pachymetry from intraoperative corneal pachymetry.

The mean flap thickness was 133.37±20.37 µm in Group A, 132.25±19.90 µm in Group B and 116.45±18.13 µm in Group C.

The researchers found that the IntraLase femtosecond FS30 created more predictable and stable flap thicknesses than the other two lasers. No significant differences were found between the Hansatome XP and the IntraLase FS2.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.